Group Testing Performance Evaluation for SARS-COV-2 Massive Scale Screening and Testing
View ORCID ProfileOzkan Ufuk Nalbantoglu
doi: https://doi.org/10.1101/2020.05.02.20080390
Ozkan Ufuk Nalbantoglu
Department of Computer Engineering and Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey

Article usage
Posted May 05, 2020.
Group Testing Performance Evaluation for SARS-COV-2 Massive Scale Screening and Testing
Ozkan Ufuk Nalbantoglu
medRxiv 2020.05.02.20080390; doi: https://doi.org/10.1101/2020.05.02.20080390
Subject Area
Subject Areas
- Addiction Medicine (271)
- Allergy and Immunology (556)
- Anesthesia (135)
- Cardiovascular Medicine (1766)
- Dermatology (173)
- Emergency Medicine (313)
- Epidemiology (10807)
- Gastroenterology (593)
- Genetic and Genomic Medicine (2958)
- Geriatric Medicine (288)
- Health Economics (534)
- Health Informatics (1932)
- Health Policy (836)
- Hematology (293)
- HIV/AIDS (632)
- Medical Education (300)
- Medical Ethics (86)
- Nephrology (324)
- Neurology (2803)
- Nursing (151)
- Nutrition (433)
- Oncology (1472)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (257)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (381)
- Pediatrics (868)
- Primary Care Research (338)
- Public and Global Health (5379)
- Radiology and Imaging (1015)
- Respiratory Medicine (727)
- Rheumatology (330)
- Sports Medicine (279)
- Surgery (327)
- Toxicology (48)
- Transplantation (150)
- Urology (126)